Login

4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma 00:00:00

Share On Facebook Share On Twitter

4D Pharma hopes to expand drug success to other areas

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"Up to seven wells" are promised by Chariot's CFO during the following 18 months. | ADONIS POUROULIS, CEO, Chariot LtdOIGLF:PKC
00:10:00
Provenance Gold Corp.: Interview with Rano Patoo on White Rock Project and Expansion Plans
00:10:00
Ville Kangasmuukko on Bubbleroom's IPO Plans and E-commerce Strategy | Ville Kangasmuukko, CEO, New Bubbleroom Sweden AB.
00:10:00
Anthony from Linden Thomas & Company: Commitment to Clients Matters
00:10:00
Investment Strategy in Uranium: A Supply-Demand Mismatch
00:10:00
Cogeco President and CEO Philippe Jetté states that Rogers Communications Inc. doesn't require certain measures, as discussed in a company video.|Frederic Perron its new president and CEO of Cogeco Communications Inc.
00:10:00
The Green Energy Transition and Its Impact on Metal Demand
00:10:00
Mastering Fund Management: Key Concepts for FRM Candidates | Michael Reeves - Senior Analyst, AnalystPrep
00:10:00
focused on startups shaping culture increasing access and resources to underserved communities|Charles D King,General Partner,MaC Venture Capital
00:10:00
Contribute to the development of innovative therapies for patients without existing or effective treatment|Cyrille Tupin,CEO,Cerenis Therapeutics Holding
00:10:00
NorthIsle Copper and Gold's Promising New Discovery at West Goodspeed
00:10:00
Transforming Financial Advising: From Personal Experience to Strategic Planning

© 2017 - Neuhu+